Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling

Page 2 of 2

Using the results demonstrated by our tactics, average investors must always pay attention to hedge fund and insider trading sentiment, and Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is an important part of this process.

Discover how hedge fund piggybacking can benefit you

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Trinity Biotech plc (ADR) (NASDAQ:TRIB) 10 0 0
Meridian Bioscience, Inc. (NASDAQ:VIVO) 11 1 3
SurModics, Inc. (NASDAQ:SRDX) 12 0 2
Quidel Corporation (NASDAQ:QDEL) 12 0 2
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) 11 0 1
Page 2 of 2